Gene therapy players Avalanche and Annapurna merge
Both Avalanche Biotechnologies and Annapurna Therapeutics are developing gene therapy candidates, with a combined pipeline that treat diseases of the eye and the heart.
paul cleveland
Both Avalanche Biotechnologies and Annapurna Therapeutics are developing gene therapy candidates, with a combined pipeline that treat diseases of the eye and the heart.